Latest filing published 27 Aug 2018 for Bionano Genomics, Inc..
Insider track record
No signal scores available.
LC Fund VI, L.P.: trading record in brief
LC Fund VI, L.P. discloses dealings in Bionano Genomics, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 23 August 2018, with 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 27 August 2018, reports a transaction in Bionano Genomics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to LC Fund VI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 199,653 sharesCommon StockSEC:0001209191-18-048557:0
- 150,550 sharesCommon StockSEC:0001209191-18-048557:1
- 637,984 sharesCommon StockSEC:0001209191-18-048557:2
- 784,728 sharesCommon StockSEC:0001209191-18-048557:3
- 1,134,000 sharesCommon StockSEC:0001209191-18-048557:4
5 of 5 declarations